Nawaf Alanazi, et al. “INVESTIGATIONS ON CLINICAL VALIDATION OF MUTATED ZNF208 AS A NOVEL BIOMARKER OF BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 29, no. 01, Jan. 2022, pp. 476-92, https://doi.org/10.53555/68zhqm37.